Coty Inc. (COTY34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 20 Oct 2026
Key indicators
| Last close | BRL 8.000 |
|---|---|
| 52-week range | 4.700 – 11.410 |
| Return, 1 month / 3 months | +27.2% / +16.8% |
| Return, 1 year / 3 years | −32.0% / −66.4% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 57.1% |
| Worst drawdown (1 year) | -58.7% |
| Average daily value traded | 0.01M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Coty Inc. is a beauty company that develops, makes and markets fragrances, colour cosmetics and skin and body care products. Its portfolio includes licensed fragrance brands tied to fashion and designer names as well as its own cosmetics and nail care labels. Customers are mainly retailers, pharmacies and duty-free operators, and the products reach consumers in many countries. The company is based in New York in the United States.
Coty Inc. is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code COTY34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Coty Inc. (COTY34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 8.000 on 20 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 876 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.0% and over the last three months it rose 16.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 23.2% | ||
| From 52-week high | -29.9% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 16.8% | ||
| 6-month return | 36.5% | ||
| 12-month return, skipping the last month | -46.6% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -58.7% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M BRL | ||
| Zero-volume days | 13.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +9.6% |
|---|---|
| 1 month | +27.2% |
| 3 months | +16.8% |
| 6 months | +36.5% |
| 1 year | −32.0% |
| 3 years | −66.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.104 / 6.493 |
|---|---|
| Golden / death cross (60 days) | Golden, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.205 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Feb 2020 | USD 0.3193 |
| 14 Feb 2020 | USD 0.2115 |
| 14 Nov 2019 | USD 0.2528 |
| 13 Nov 2019 | USD 0.3878 |
| 6 Sep 2019 | USD 0.2602 |
| 5 Sep 2019 | USD 0.1724 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.